New device aims to help NMOSD patients walk again
NCT ID NCT06374264
First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 25 times
Summary
This study tests a device called MR-C-014 to see if it is safe and acceptable for people with neuromyelitis optica spectrum disorder (NMOSD) who have trouble walking. About 30 adults aged 18-70 will use the device for 8 weeks, walking 3 times per week. Researchers will track how often participants use it and any side effects, and measure walking distance improvements.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Sheperd Center
Atlanta, Georgia, 30309, United States
Conditions
Explore the condition pages connected to this study.